Koninklijke Philips NV (PHIA)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
€22.21
Buy
€22.48
€-0.19 (-0.84%)
Prices updated at 17 Dec 2025, 16:35 CET
| Prices minimum 15 mins delay
Prices in EUR
Royal Philips NV is a health technology company. The company provides various services in the area of personal health, diagnosis and treatment, connected care and health informatics businesses, and health tech.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 18,169m | 18,021m | |
| 7,448m | 7,773m | |
| -168m | 513m | |
| -0.92 | 2.85 | |
| -466m | -702m | |
| 1,041m | 1,849m | |
| Sales, General and administrative | 5,132m | 5,068m |
| Interest expenses | 306m | 337m |
| Provision for income taxes | -73m | 963m |
| Operating expenses | 7,616m | 7,260m |
| Income before taxes | -526m | 123m |
| Net income available to common shareholders | -466m | -702m |
| -0.472049 | -0.75 | |
| Net interest income | -266m | -257m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | -0.472049 | -0.75 |
| Free cash flow per share | -0.0572 | 1.2054 |
| Book value/share | 12.9362 | 12.8474 |
| Debt equity ratio | 0.578567 | 0.58704 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 9,940m | 10,022m |
| Current liabilities | 8,285m | 8,144m |
| Total capital | 18,123m | 18,200m |
| Total debt | 7,613m | 7,491m |
| Total equity | 12,028m | 12,006m |
| Total non current liabilities | - | - |
| Loans | 6,095m | 6,194m |
| Total assets | 29,406m | 28,976m |
| Total liabilities | - | - |
| Cash and cash equivalents | 1,869m | 2,401m |
| Common stock | 937m | 925m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 1,172m | 1,869m |
| Cash dividends paid | -2m | -1m |
| 1,492m | 893m | |
| Investments (gains) losses | -636m | -573m |
| 1,869m | 2,401m | |
| Net income | - | - |
| 2,136m | 1,569m | |
| -644m | -676m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
